SCHEMBL8096835

SCHEMBL8096835

CC(C)(NCCCc1ccc2ccccc2c1)c1ccccc1.CC(C)(NCCCc1cccc2ccccc12)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 6/20 0.46
MC5R P33032 2/20 0.46
MAPK1 P28482 1/20 0.46
MC3R P41968 2/20 0.41
MC4R P32245 1/20 0.41
MC1R Q01726 1/20 0.41
CASR P41180 3/20 0.41
ADRA2C P18825 2/20 0.41
SLC6A2 P23975 2/20 0.41
HTR2C P28335 2/20 0.41
SLC6A4 P31645 2/20 0.41
OPRM1 P35372 2/20 0.41
DRD3 P35462 2/20 0.41
MLNR O43193 1/20 0.41
ABCB11 O95342 1/20 0.41
ADRB1 P08588 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
CYP2D6 P10635 1/20 0.41
CHRM1 P11229 1/20 0.41
DRD2 P14416 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8091054 0.89 SIGMAR1 (0.53) SIGMAR1MC5RMC3RMC4RCASR
SCHEMBL8099974 0.89 SIGMAR1 (0.52) SIGMAR1CASRSLC6A2SLC6A4CYP2D6
SCHEMBL8100039 0.81 NQO2 (0.51) SIGMAR1CASRSLC6A2SLC6A4CYP2D6
SCHEMBL8093077 0.81 CASR (0.49) SIGMAR1MC5RMC4RCASRCYP1A2
SCHEMBL8096840 0.75 SIGMAR1 (0.50) SIGMAR1MC5RMAPK1MC3RMC4R
SCHEMBL8091780 0.73 SIGMAR1 (0.53) SIGMAR1CYP2D6CYP1A2
SCHEMBL932837 0.73 MC5R (0.63) SIGMAR1MC5RMAPK1MC3RMC4R
SCHEMBL7212154 0.73 SLC6A2 (0.60) SIGMAR1MC3RCASRADRA2CSLC6A2
SCHEMBL20898202 0.71 CYP1A2 (0.68) MC5RMAPK1MC3RMC4RMC1R
Phenylbutanoic Acid SCHEMBL20897923 0.71 CYP1A2 (0.72) MC5RMAPK1MC3RMC4RMC1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6057371-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, GASTROINTESTINAL DISORDERS, DRUG ABUSE, ANGINA, MIGRAINE, HYPERTENSION AND DEPRESSION VIRGINIA COMMONWEALTH UNIVERSITY (US) 2000-05-02 US claimed